Health Care & Life Sciences » Biotechnology | Edge Therapeutics Inc.

Edge Therapeutics Inc. | Ownership

Companies that own Edge Therapeutics Inc.

Name
Shares Held
% Shares Out
Change In Shares
% of Assets
As of Date
The Vanguard Group, Inc.
857,987
2.75%
34,604
0%
06/30/2018
D. E. Shaw & Co. LP
856,666
2.74%
821,704
0%
06/30/2018
Ghost Tree Capital LLC
750,792
2.4%
750,792
0.18%
06/30/2018
Millennium Management LLC
510,212
1.63%
491,899
0%
06/30/2018
BlackRock Fund Advisors
333,636
1.07%
-761,560
0%
06/30/2018
Two Sigma Investments LP
267,436
0.86%
234,992
0%
06/30/2018
A.R.T. Advisors LLC
247,674
0.79%
234,318
0.01%
06/30/2018
Renaissance Technologies LLC
246,700
0.79%
3,300
0%
06/30/2018
Geode Capital Management LLC
240,153
0.77%
38,084
0%
06/30/2018
Raymond James Financial Services Advisors, Inc.
158,463
0.51%
158,463
0%
06/30/2018

About Edge Therapeutics

View Profile
Address
300 Connell Drive
Berkeley Heights New Jersey 07922
United States
Employees -
Website http://www.edgetherapeutics.com
Updated 09/14/2018
Edge Therapeutics, Inc. is clinical-stage biotechnology company, which engages in the discovery, development, and commercialization of novel, hospital-based therapies capable of transforming treatment paradigms in the management of acute, life-threatening neurological and other conditions. Its product candidate is the EG-1962. The company was founded on January 22, 2009 by Brian A.

StatInvestor

Privacy Policy
Feedback

© 2024 StatInvestor All Rights Reserved.